ENTITY
MicroPort CardioFlow

MicroPort CardioFlow (2160 HK)

63
Analysis
Health Care • China
MicroPort CardioFlow Medtech Corporation is a medical device company specializing in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases. Its product portfolio includes transcatheter aortic valves, left atrial appendage closure systems, and cardiac rhythm management devices like pacemakers and implantable cardioverter-defibrillators. The company was founded in 2015 and is headquartered in Shanghai, China.
more
•17 May 2021 09:04

Microport Scientific (853.HK) - It Is a Good Time to See Some Concerns

This article analyzed Microport's core businesses after its worst financial performance in 2020, the policy impact, the potential risks, the...

Logo
370 Views
Share
•22 Mar 2021 09:16

Venus MedTech Vs MicroPort CardioFlow

This article analyzed the difference between MicroPort CardioFlow and Venus Medtech in terms of sales performance, product progress, industry...

Logo
493 Views
Share
bullish•Kuaishou Technology
•31 Jan 2021 11:06

ECM Weekly (31 January 2021) - Kuaishou, Basecare Med, MicroPort Cardioflow, Cloopen

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
•27 Jan 2021 11:02

MicroPort CardioFlow: What You Have to Assume

We think that the proposed valuation for MicroPort CardioFlow's HKEX listing is pricey, but the business has very good momentum. We would take the...

Share
•27 Jan 2021 09:08

Cardioflow (å¾®åˆ›åæƒé€š)Ā  IPO: Limited Upside

We think the cornerstone line up is not the best for a healthcare listing and there's also a limited upside of 10% at the high end despite a strong...

Logo
497 Views
Share
x